Comparing the effect of shafa ointment and Diclophenac ointment in patiants that affected to knee osteoarthritis
Phase 2
Recruiting
- Conditions
- osteoarthritis of knee.M17 =Gonarthrosis [arthrosis of knee]
- Registration Number
- IRCT20170916036211N2
- Lead Sponsor
- Booali Pharmaceutical Company
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
age range 18 to 50 years old; clinical symptoms including bone pain when pressure applied; bone enlargement; lack of local heating; crepitus ? limitation of knee range of motion ; feeling moderate knee pain based on the Western Ontario & McMaster Universities Osteoarthritis (WOMAC) index.
Exclusion Criteria
lack of patient’s cooperation or willingness; acute knee osteoarthritis; secondary osteoarthritis; disabling diseases such as osteoarticular and infectious diseases; severe pain that required another sedative agent.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of knee pain. Timepoint: befor intervention, 7 weeks after start of treatment. Method of measurement: womac questionnaire.
- Secondary Outcome Measures
Name Time Method Joint stiffness. Timepoint: befor intervention, 7 weeks after start of treatment. Method of measurement: womac questionnaire.;Restriction of movement. Timepoint: befor intervention, 7 weeks after start of treatment. Method of measurement: womac questionnaire.